A Transformative Vision for an Omics-Based Regulatory Chemical Testing Paradigm. (27th September 2022)

• Record Type: Journal Article
• Authors: Johnson, Kamin J; Auerbach, Scott S; Stevens, Tina; Barton-Maclaren, Tara S; Costa, Eduardo; Currie, Richard A; Dalmas Wilk, Deidre; Haq, Saddef; Rager, Julia E; Reardon, Anthony J F; Wehmas, Leah; Williams, Andrew; O'Brien, Jason; Yauk, Carole; LaRocca, Jessica L; Pettit, Syril
• Is Part Of: Toxicological sciences. Volume 190:Number 2(2022)
• Page Start: 127
• Page End: 132
• Publication Date: 2022-09-27
• Subjects: risk assessment -- toxicogenomics -- point of departure -- transcriptomics; Toxicology -- Periodicals; Toxicology -- Periodicals; Toxicology; Periodicals; 615.9
• DOI: 10.1093/toxsci/kfac097
• Languages: English
• ISSNs: 1096-6080

Abstract

Abstract: Use of molecular data in human and ecological health risk assessments of industrial chemicals and agrochemicals has been anticipated by the scientific community for many years; however, these data are rarely used for risk assessment. Here, a logic framework is proposed to explore the feasibility and future development of transcriptomic methods to refine and replace the current apical endpoint-based regulatory toxicity testing paradigm. Four foundational principles are outlined and discussed that would need to be accepted by stakeholders prior to this transformative vision being realized. Well-supported by current knowledge, the first principle is that transcriptomics is a reliable tool for detecting alterations in gene expression that result from endogenous or exogenous influences on the test organism. The second principle states that alterations in gene expression are indicators of adverse or adaptive biological responses to stressors in an organism. Principle 3 is that transcriptomics can be employed to establish a benchmark dose-based point of departure (POD) from short-term, in vivo studies at a dose level below which a concerted molecular change (CMC) is not expected. Finally, Principle 4 states that the use of a transcriptomic POD (set at the CMC dose level) will support a human health-protective risk assessment. If all four principles are substantiated, this vision is expected to transform aspects of the industrial chemical and agrochemical risk assessment process that are focused on establishing safe exposure levels for mammals across numerous toxicological contexts resulting in a significant reduction in animal use while providing equal or greater protection of human health. Importantly, these principles and approaches are also generally applicable for ecological safety assessment.